Galectin Therapeutics Inc. (GALT) Social Stream
GALECTIN THERAPEUTICS INC (GALT) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering GALT.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-04-01 | 1 | $14 | $14 | $14 | $1.29 | 985.27% |
| 2022-11-15 | 1 | $11 | $11 | $11 | $1.29 | 752.71% |
Price Target Last Issued November 15, 2022
The Trend in the Analyst Price Target
Over the past 15 months, GALT's average price target has gone down $3.
GALT reports an average of 673.14% for its upside potential over the past 33 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-04-01 | 1 | 14 | 14 | 14 | 1.58 | 786.08% |
| 2022-05-17 | 1 | 11 | 11 | 11 | 1.35 | 714.81% |
| 2022-08-16 | 1 | 11 | 11 | 11 | 2.18 | 404.59% |
| 2022-11-15 | 1 | 11 | 11 | 11 | 1.24 | 787.1% |
GALT Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 1 | 0 | 0 | 0 | 0 | 1 |
The Trend in the Broker Recommendations
Over the past 52 weeks, GALT's average broker recommendation rating improved by 0.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for GALT as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, GALECTIN THERAPEUTICS INC's number of analysts covering the stock is higher than nearly none of them.
- To contextualize these metrics, consider that out of all US stocks, GALECTIN THERAPEUTICS INC's variance in analysts' estimates is lower than just about 100% of them.
- To contextualize these metrics, consider that out of stocks in the small market cap category, GALECTIN THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is greater than 174.91% of them.
- GALECTIN THERAPEUTICS INC's average analyst price target is higher than 46.41% of Healthcare stocks.
In the Pharmaceutical Products industry, ORIC, AKUS, and PNT are the three stocks most similar to GALECTIN THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
What is the outlook for GALT? Use POWR Ratings for clearer insight into price direction.